Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinoma. [electronic resource]
Producer: 20091124Description: 738-47 p. digitalISSN:- 1873-5576
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Bevacizumab
- Carcinoma, Hepatocellular -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Hep G2 Cells
- Humans
- Indoles -- pharmacology
- Liver Neoplasms -- drug therapy
- Liver Neoplasms, Experimental -- drug therapy
- Mice
- Mice, SCID
- Neovascularization, Pathologic -- drug therapy
- Phosphorylation -- drug effects
- Pyrroles -- pharmacology
- Sunitinib
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.